Telehealth Intervention to Improve Uptake of Evidence-Based Medications among Patients with Type 2 Diabetes and Heart Failure or Cardiovascular Disease

Introduction: Sodium glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor (GLP-1) agonists are recommended for patients with type two diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF) to reduce cardiovascular-related mortality. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva-Almodóvar, Armando, Nahata, Milap C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964915/
https://www.ncbi.nlm.nih.gov/pubmed/36834307
http://dx.doi.org/10.3390/ijerph20043613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964915/
https://www.ncbi.nlm.nih.gov/pubmed/36834307
http://dx.doi.org/10.3390/ijerph20043613

Ejemplares similares